GlassScriptPhysician profile
Mohammad H Madantschi
NPI 1710103023
$8,426.42
in general payments reported to CMS, 2019-2025
20 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,120 · 2020: $574 · 2021: $363 · 2022: $52.11 · 2023: $173 · 2024: $5,811 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $1,342 · Travel and Lodging: $966 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $1,342.28 |
| Travel and Lodging | $966.46 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,955.90 | 2023-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $631.38 | 2019-2025 | Breztri, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $415.94 | 2019-2024 | |
| United Therapeutics Corporation | $276.50 | 2019-2021 | |
| Glaxosmithkline, LLC. | $229.47 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $200.55 | 2019-2021 | |
| Genentech USA, INC. | $182.57 | 2019-2020 | |
| Amgen INC. | $120.82 | 2019 | |
| Pfizer INC. | $119.50 | 2019 | |
| Philips North America LLC | $51.51 | 2019-2020 | |
| Grifols USA, LLC | $47.56 | 2019-2020 | |
| Electromed, INC. | $39.15 | 2022 | |
| Circassia INC. | $30.67 | 2019 | |
| Gilead Sciences, INC. | $28.57 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.11 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.51 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.24 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.03 | 2019 | |
| Mylan Specialty L.P. | $11.98 | 2020 | |
| 3b Medical, INC. | $11.46 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Madantschi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.